Literature DB >> 12164286

Analysis of T helper cell responses during infection with Leishmania amazonensis.

Jiaxiang Ji1, Jiaren Sun, Hai Qi, Lynn Soong.   

Abstract

Most inbred strains of mice are susceptible to Leishmania amazonensis infection and develop progressive cutaneous lesions. However, the role of Th subsets in the disease and the molecular basis of pathogenesis are unclear. To address this issue, we examined the frequency of cytokine-producing CD4+ T cells and the profile of alphabeta T cell receptor (TCR) usage in infected BALB/c mice. At different infection stages, CD4+ cells of draining lymph nodes contained comparable frequencies of Th1 and Th2 cells, produced comparable levels of interleukin-4 (IL-4) and interferon-gamma in vitro, and showed no significant bias in aalphabetaTCR usage. However, T cells became highly polarized to a Th2 phenotype (IL-4+, IL-10+) within a few cycles of in vitro restimulation. These Th2 cells preferentially expressed Valpha2, Vbeta4, or Vbeta8.1/8.2, and significantly exacerbated disease in cell-transferred mice. Thus, unlike a Th2-dominant phenotype seen in L. major infection, a mixed Th1/Th2 response can be maintained in L. amazonensis-infected mice via an as-yet-unidentified mechanism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12164286     DOI: 10.4269/ajtmh.2002.66.338

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  38 in total

1.  Multifunctional CD4⁺ T cells in patients with American cutaneous leishmaniasis.

Authors:  A B B Macedo; J C Sánchez-Arcila; A O Schubach; S C F Mendonça; A Marins-Dos-Santos; M de Fatima Madeira; T Gagini; M I F Pimentel; P M De Luca
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

2.  Type I IFN receptor regulates neutrophil functions and innate immunity to Leishmania parasites.

Authors:  Lijun Xin; Diego A Vargas-Inchaustegui; Sharon S Raimer; Brent C Kelly; Jiping Hu; Leiyi Zhu; Jiaren Sun; Lynn Soong
Journal:  J Immunol       Date:  2010-05-12       Impact factor: 5.422

3.  Effects of CXCL10 on dendritic cell and CD4+ T-cell functions during Leishmania amazonensis infection.

Authors:  René E Vasquez; Lijun Xin; Lynn Soong
Journal:  Infect Immun       Date:  2007-11-12       Impact factor: 3.441

4.  A deficiency in the B cell response of C57BL/6 mice correlates with loss of macrophage-mediated killing of Leishmania amazonensis.

Authors:  Katherine N Gibson-Corley; Paola M Boggiatto; Rami M Mukbel; Christine A Petersen; Douglas E Jones
Journal:  Int J Parasitol       Date:  2009-12-11       Impact factor: 3.981

5.  Sand fly saliva enhances Leishmania amazonensis infection by modulating interleukin-10 production.

Authors:  Nilufer B Norsworthy; Jiaren Sun; Dia Elnaiem; Gregory Lanzaro; Lynn Soong
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

Review 6.  Modulation of dendritic cell function by Leishmania parasites.

Authors:  Lynn Soong
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

7.  DNA immunization with the gene encoding P4 nuclease of Leishmania amazonensis protects mice against cutaneous Leishmaniasis.

Authors:  Kimberly Campbell; Hong Diao; Jiaxiang Ji; Lynn Soong
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

8.  Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis.

Authors:  Jiaxiang Ji; Jiaren Sun; Lynn Soong
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  Down-regulation of dendritic cell signaling pathways by Leishmania amazonensis amastigotes.

Authors:  Lijun Xin; Kui Li; Lynn Soong
Journal:  Mol Immunol       Date:  2008-06-05       Impact factor: 4.407

10.  Antigen-responsive CD4+ T cells from C3H mice chronically infected with Leishmania amazonensis are impaired in the transition to an effector phenotype.

Authors:  Amanda E Ramer; Yannick F Vanloubbeeck; Douglas E Jones
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.